(Q28343882)

PubMed

alkylating antineoplastic agent

12 November 2019

1 reference

25 September 2020

1 reference

20 January 2021

1 reference

J Pelgrims

1

0 references

F De Vos

2

0 references

J Van den Brande

3

0 references

D Schrijvers

4

0 references

A Prové

5

0 references

J B Vermorken

British Journal of Cancer

6

0 references

language of work or name

English

0 references

publication date

January 2000

0 references

1 January 2000

7 references

25 April 2019

17 September 2019

2 October 2019

7 November 2019

12 November 2019

25 September 2020

20 January 2021

7 references

25 April 2019

17 September 2019

2 October 2019

7 November 2019

12 November 2019

25 September 2020

20 January 2021

82

0 references

issue

2

0 references

page(s)

291-4

0 references

cites work

Encephalopathy in ifosfamide-treated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue.

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Ifosfamide metabolism and pharmacokinetics (review).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

The genesis of alcoholic brain tissue injury

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Methylene blue in ifosfamide-induced encephalopathy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Ifosfamide encephalopathy and methylene-blue: a case report

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Successful treatment with methylene blue of ifosfamide-induced central nervous system effects

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Hallucinations and ifosfamide-induced neurotoxicity

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Methylene blue for ifosfamide-associated encephalopathy

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Treatment of ifosfamide induced encephalopathy with methylene-blue

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Methylene-blue for riboflavin-unresponsive glutaricaciduria type II.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Modifying intracellular redox balance: an approach to improving therapeutic index

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Ifosfamide by continuous infusion to prevent encephalopathy.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Ifosfamide-induced neurotoxicity

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363270

Metabolism and pharmacokinetics of oral and intravenous ifosfamide

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10646879